Investing.com - Boston Scientific (NYSE:BSX) reported third quarter earnings that beat analysts' expectations on Wednesday and revenue that topped forecasts.
The firm reported earnings per share of $0.39 on revenue of $2.71B. Analysts polled by Investing.com forecast EPS of $0.38 on revenue of $2.65B. That compared to EPS of $0.35 on revenue of $2.39B in the same period a year earlier. The company had reported EPS of $0.39 on revenue of $2.63B in the previous quarter.
For the year, Boston Scientific shares are up 5.21%, under-performing the S&P Global (NYSE:SPGI) 100 which is up 17.17% year to date.
Boston Scientific follows other major Healthcare sector earnings this month
On Tuesday, October 15, 2019, J&J reported third quarter EPS of $2.12 on revenue of $20.73B, compared to forecasts of EPS of $2.01 on revenue of $20.08B.
Novartis ADR earnings beat analyst's expectations on Tuesday, with third quarter EPS of $1.41 on revenue of $12.17B. Investing.com analysts expected EPS of $1.33 on revenue of $11.71B
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar